CureVac vs Ray Therapeutics
CureVac vs Ray Therapeutics, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: CureVac is on 40/100 and Ray Therapeutics on 53/100.
Where each one leads
CureVac
- agent readiness: 38/100 against 21/100
- domain rating: 66/100 against 29/100
- funding raised: $2.1B against $243M
Ray Therapeutics
- our overall score: 53/100 against 40/100
At a glance
| Measure | CureVac | Ray Therapeutics |
|---|---|---|
| What it is | Biopharmaceutical company developing mRNA-based vaccines and therapeutics for infectious diseases and cancer. | Pioneering vision restoration therapies for severe retinal degenerations. |
| Category | Biotech, MedTech, HealthTech, Drug Discovery | Biotechnology, Pharmaceuticals, Healthcare, Medical Devices |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Services |
| Founded | 2000 | 2021 |
| Headquarters | Tübingen, Germany | Berkeley, USA |
| Status | Active | Active |
Size, funding and growth
| Measure | CureVac | Ray Therapeutics |
|---|---|---|
| Total funding | $2.1B | $243M |
| Latest round | IPO | Series B |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | CureVac | Ray Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 40/100 | 53/100 |
| Traction | 40/100 | 40/100 |
| Team | Not published | 50/100 |
| Search visibility | 3/100 | 14/100 |
| Quality | 55/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (38/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 66/100 | 29/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | CureVac | Ray Therapeutics |
|---|---|---|
| Hosting | Hetzner | Not detected |
| CDN | Not detected | Cloudflare |
| CMS | Not detected | WordPress |
| Frameworks | Not detected | Jquery |
| Analytics | Not detected | Google Analytics 4 |
CureVac vs Ray Therapeutics: common questions
Which is better, CureVac or Ray Therapeutics?
On our 0-100 score Ray Therapeutics rates higher (53/100 against 40/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.
How do CureVac and Ray Therapeutics compare on the numbers?
CureVac leads on agent readiness (38/100 against 21/100), domain rating (66/100 against 29/100), funding raised ($2.1B against $243M). Ray Therapeutics leads on our overall score (53/100 against 40/100).
Read the full CureVac review and pricing or the Ray Therapeutics review and pricing. You can also browse other CureVac alternatives we track.